Q-Slim® patent is based on data collected at the University of Minnesota
Q-Slim® matches up to US Patent No.6,899,892 in which the invention provides a method and composition for reducing the level of Leptin in the bloodstream and correspondingly reduction in the percentage of body fat.

• The patent also claims sufficient reductions in the level of serum Leptin in the bloodstream to beneficial or efficacious levels in approximately three to six weeks.

Q-Slim® has the attached rights of employing the patent number on labels and brochures. At efficacious levels, suggested structure-function or marketing statements may include the following:

• Assists in promoting fat loss
  (Supported by US Patent 6,899,892 and references 1, 2 and 3 ).
• Assists in promoting a lower percentage of body fat
  (Supported by US Patent 6,899,892 and references 1, 2, 3 and 4).
• Promotes the reduction of stored fat by increasing fatty acid utilization in the fat cell (Supported by references 4 and 5).
• Promotes the reduction of fat and an enhanced muscle to fat ratio
  (Supported by references 1, 2, 3 and 4).
• Promotes the regulation of energy balance allowing for improved mental energy (Supported by references 6 and 7).

References

Eikelis N and Esler M. The neurobiology of human obesity. Exp Physiol. 2005; (90)5: 673 - 682.   Drevon CA. Fatty acids and expression of adipokines.   Bichimica et Biophysica Acta 2005, 1740: 287-292. Meier U, Gressner AM. Endocrine regulation of energy metabolism: Review of pathobiochemical and clinical chemical aspects of Leptin, ghrelin, @adiponectin and resistin. Clin Chemistry 2004, 50(9): 1511-1525. Cohen P, Miyazaki M, Socci ND, Hagge-Greenberg A, Liedtke W, Soukas AA, Sharma R, Hudgins LC, Ntambi JM, Friedman JM. Role for stearoyl-CoA desaturase-1 in Leptin-mediated weight loss. Science. 2002 12; 297(5579):240-3. Cohen P, Friedman JM. Leptin and the control of metabolism:role for stearoyl-CoA desaturase-1 (SCD-1). J Nutr. 2004 Sep; 134(9):2455S-2463S. Greenwood CE, Winocur G. High-fat diets, insulin resistance and declining cognitive function.   Neurobiol Aging. 2005 Oct 27. Elias MF, Elias PK, Sullivan LM, Wolf PA, D'Agostino RB. Obesity, diabetes and cognitive deficit: The Framingham Heart Study. Neurobiol Aging. 2005 Oct 10.